Latest News About Attention Deficit Hyperactivity Disorder

Here are the latest ADHD news highlights from reliable outlets and research summaries:

• Major reviews in late 2025confirm ADHD prevalence in the general population remains stable, with improved diagnostic tools helping identify cases more accurately rather than indicating a true surge in incidence. This counters sensational headlines about an “epidemic” of ADHD and emphasizes better screening practices.[3]
• Research in 2025–2026 highlights ADHD is associated with increased risks for certain adverse outcomes across the life course, including reduced life expectancy in some analyses, but also shows that appropriate treatment, including stimulant medications, can mitigate some risks (e.g., safety benefits reported in large-scale studies).[1][3]
• Several large reviews and news digests note ongoing discussions about ADHD medication use in pregnancy, with several sources reporting safety profiles for commonly prescribed stimulants and non-stimulants, though guidance emphasizes individualized risk-benefit decisions and consultation with healthcare providers.[4][3]
• News themes from 2025 foreground the expansion of ADHD research into comorbid conditions and genetic profiles, with reporting suggesting more nuanced understandings of ADHD alongside co-occurring conditions (e.g., interactions with autism spectrum traits).[3]
• Media coverage in late 2025 and early 2026 also reflects ongoing education efforts for clinicians and educators about ADHD, including how to interpret new research findings and how to translate them into practical strategies for assessment and management in various settings.[2][7]

If you’d like, I can pull the full articles or provide a brief synthesis focused on a specific aspect (medication safety, prevalence trends, adults vs. children, educational implications, or policy developments) with direct quotes and quotations from the sources. I can also set up a quick, shareable summary for you.